Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve P Kanter

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
JAMA Health Forum|July 7, 2023
The Real Question the FDA Is Asking Its Advisory CommitteesGenevieve P Kanter
JAMA Health Forum|October 11, 2022
COVID-19 and the Future of Drug MarketingGenevieve P Kanter
JAMA Internal Medicine|November 12, 2019
Public Comments and Industry Interests in Medicaid Coverage DecisionsGenevieve P Kanter
American Journal of Public Health|July 12, 2018
Extending the Sunshine Act From Physicians to Patient Advocacy OrganizationsGenevieve P Kanter
The New England Journal of Medicine|March 23, 2026
Conflicts of Interest in Advisory Committees - Facts, Fallacies, and the Limits of ReformGenevieve P Kanter
JAMA|July 2, 2019
Evaluating Open PaymentsGenevieve P Kanter, George Loewenstein
Journal of the Endocrine Society|October 23, 2019
US Growth Hormone Use in the Idiopathic Short Stature Era: Trends in Insurer Payments and Patient Financial BurdenAdda Grimberg, Genevieve P Kanter
Health Affairs (Project Hope)|September 5, 2023
The Revolving Door In Health Care RegulationGenevieve P Kanter, Daniel Carpenter
The New England Journal of Medicine|January 31, 2019
Coordination of Care or Conflict of Interest? Exempting ACOs from the Stark LawGenevieve P Kanter, Mark V Pauly
JAMA|September 8, 2018
Campaign Contributions From Political Action Committees to Members of Congressional Committees Responding to the Opioid CrisisMatthew S McCoy, Genevieve P Kanter
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
JAMA Health Forum|July 7, 2023
The Real Question the FDA Is Asking Its Advisory CommitteesGenevieve P Kanter
JAMA Health Forum|October 11, 2022
COVID-19 and the Future of Drug MarketingGenevieve P Kanter
JAMA Internal Medicine|November 12, 2019
Public Comments and Industry Interests in Medicaid Coverage DecisionsGenevieve P Kanter
American Journal of Public Health|July 12, 2018
Extending the Sunshine Act From Physicians to Patient Advocacy OrganizationsGenevieve P Kanter
The New England Journal of Medicine|March 23, 2026
Conflicts of Interest in Advisory Committees - Facts, Fallacies, and the Limits of ReformGenevieve P Kanter
JAMA|July 2, 2019
Evaluating Open PaymentsGenevieve P Kanter, George Loewenstein
Journal of the Endocrine Society|October 23, 2019
US Growth Hormone Use in the Idiopathic Short Stature Era: Trends in Insurer Payments and Patient Financial BurdenAdda Grimberg, Genevieve P Kanter
Health Affairs (Project Hope)|September 5, 2023
The Revolving Door In Health Care RegulationGenevieve P Kanter, Daniel Carpenter
The New England Journal of Medicine|January 31, 2019
Coordination of Care or Conflict of Interest? Exempting ACOs from the Stark LawGenevieve P Kanter, Mark V Pauly
JAMA|September 8, 2018
Campaign Contributions From Political Action Committees to Members of Congressional Committees Responding to the Opioid CrisisMatthew S McCoy, Genevieve P Kanter
Pageof 6